Eyenuk Raises $26M in Series A Funding

Eyenuk

Eyenuk, a Los Angeles, CA-based synthetic intelligence (AI) virtual well being corporate, raised $26M in Collection A investment.

The spherical, which brings overall investment to over $43m, was once led by means of AXA IM Alts with participation from T&W Clinical A/S, A&C Foelsgaard Alternativer ApS, Kendall Capital Companions, and KOFA Healthcare. As a part of the capital carry, Rob Binney has joined the Eyenuk Board of Administrators because the Board’s Chair. Binney is a veteran govt with 25 years of mixed senior management enjoy within the clinical software and pharmaceutical industries. Additionally becoming a member of the board are Zina Affas Besse, and Marie-Louise Little, Director of Technique and Industry Building at T&W Clinical A/S. 

The corporate intends to make use of the price range to extend its AI product platform with further illness indications and complex care coordination, and to boost up the platform’s world commercialization and adoption.

Led by means of CEO and Founder Kaushal Solanki, Eyenuk is a synthetic intelligence (AI) virtual well being corporate offering an AI Eye Screening for independent illness detection and AI Predictive Biomarkers™ for chance review and illness surveillance. The corporate is on a challenge to display screen each and every eye on the earth to make sure well timed analysis of life- and vision-threatening illnesses, together with diabetic retinopathy, glaucoma, age-related macular degeneration, stroke chance, cardiovascular chance, and Alzheimer’s illness. Its flagship EyeArt AI machine has been extra extensively followed international than another independent AI era for ophthalmology. Since its FDA clearance in 2020, the EyeArt machine has been utilized in over 200 places in 18 nations, together with 14 U.S. states, to display screen over 60,000 sufferers and counting. It was once cleared by means of the FDA for independent detection of each referable and vision-threatening diabetic retinopathy with none eye care specialist involvement. The EyeArt machine is reimbursed by means of Medicare in america, and has regulatory approvals globally, together with CE Marking, Well being Canada license, and approvals in a couple of markets in Latin The usa and the Center East.

FinSMEs

17/10/2022

Leave a Comment